Influenza Market Global Scenario Market Size, Outlook, Trend and Forecast, 2016 2022
Global Influenza Market is expected to reach USD 9.33 billion by 2021 from USD 5.97 billion in 2016, growing at a CAGR of 8.54% during the forecast period, 2016-2021.
(EMAILWIRE.COM, December 15, 2017 ) Influenza or flu is a transmittable respiratory disease which affect nose, throat, and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be either seasonal, pandemic, or zoonotic. Influenza market can be fatal if goes unnoticed and is regarded as a major reason of morbidity and mortality, globally.
Some of the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue, headache, and body ache. According to World Health Organization, the flu occurs annually infecting 5% to 10% adults and 20% to 30% children, worldwide. Approximately, 3 to 5 million people gets severely infected resulting in 250,000 500,000 deaths. Children below 2 years of age and elderly above 65 years of age are at high risk of developing chronic flu.
View Full Report @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, increase in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, especially in Asian and African countries are not immunized against influenza virus, thereby fueling the demand for the product in developing and under developed economies. The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, side-effects of the product (soreness, swelling, and redness), lack of advanced technology for early detection of new influenza virus, and remote areas with limited accessibility.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-sample
The global Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults. Vaccines (Fluzone, Afluria, Fluvirin, Flublok, and others) commands major market share which is estimated to be more than 80% and is anticipated to be fastest growing segment during forecast period.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/inquire
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 50% in 2016.
The major companies dominating the global Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).
Market Segmentation
1 Product Type
1.1 Introduction
1.2 Vaccines
1.3 Drugs
2 Type
2.1 Introduction
2.2 Safety Biomarkers
2.3 Efficacy Biomarkers
2.4 Validation Biomarkers
3 Application
3.1 Introduction
3.2 Diagnostics Development
3.3 Drug Discovery and Development
3.4 Personalised Medicine
3.5 Disease Risk Assessment
3.6 Other Applications
4 Disease Indications
4.1 Introduction
4.2 Cancer
4.3 Cardiovascular Disorders
4.4 Neurological Disorders
4.5 Immunological Disorders
4.6 Other Diseases
Scope of the Report
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Some of the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue, headache, and body ache. According to World Health Organization, the flu occurs annually infecting 5% to 10% adults and 20% to 30% children, worldwide. Approximately, 3 to 5 million people gets severely infected resulting in 250,000 500,000 deaths. Children below 2 years of age and elderly above 65 years of age are at high risk of developing chronic flu.
View Full Report @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, increase in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, especially in Asian and African countries are not immunized against influenza virus, thereby fueling the demand for the product in developing and under developed economies. The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, side-effects of the product (soreness, swelling, and redness), lack of advanced technology for early detection of new influenza virus, and remote areas with limited accessibility.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-sample
The global Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults. Vaccines (Fluzone, Afluria, Fluvirin, Flublok, and others) commands major market share which is estimated to be more than 80% and is anticipated to be fastest growing segment during forecast period.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/inquire
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 50% in 2016.
The major companies dominating the global Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).
Market Segmentation
1 Product Type
1.1 Introduction
1.2 Vaccines
1.3 Drugs
2 Type
2.1 Introduction
2.2 Safety Biomarkers
2.3 Efficacy Biomarkers
2.4 Validation Biomarkers
3 Application
3.1 Introduction
3.2 Diagnostics Development
3.3 Drug Discovery and Development
3.4 Personalised Medicine
3.5 Disease Risk Assessment
3.6 Other Applications
4 Disease Indications
4.1 Introduction
4.2 Cancer
4.3 Cardiovascular Disorders
4.4 Neurological Disorders
4.5 Immunological Disorders
4.6 Other Diseases
Scope of the Report
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results